Luigi Naldini, Pierluigi Paracchi, Carlo Russo. Genenta
Italian gene therapy player draws new investor from China for its answer to CAR-T relapses
So you’ve been treated with one of the new-age cancer therapies. What do you do if there’s a relapse and the tumors returns …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
